Phibro Animal Health (PAHC) Reports In-Line Q3 EPS, Offers Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $212 million versus the consensus estimate of $208.05 million.

GUIDANCE:

Phibro Animal Health sees Q4 2021 EPS of $0.30-$0.32, versus the consensus of $0.28. Phibro Animal Health sees Q4 2021 revenue of $213-217 million, versus the consensus of $200 million.

Phibro Animal Health sees FY2021 EPS of $1.20-$1.22, versus the consensus of $1.21. Phibro Animal Health sees FY2021 revenue of $826.1-830.1 million, versus the consensus of $805.9 million.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Resumes Gap, Inc. (GAP) at Equalweight
• Morgan Stanley Resumes Bath & Body Works Inc. (BBWI) at Equalweight